Filter posts

The New Road to IPO in the Age of the JOBS Act

Not surprisingly, sessions discussing the topic of IPOs at this year’s BIO Investor Forum, tend …

BIO Patient and Health Advocacy Summit: Patient-Focused Drug Development

Panelists in this morning’s opening session outlined strategies for the FDA to better engage the …

Biotech IPO Boom or Bubble? The Opening Plenary at the BIO Investor Forum

With 31 (and counting) life sciences companies having already placed IPOs on the market within …

Successful Public-Private Partnerships

According to BayBio, biomedical companies that can harness the power of patient groups will get …

BIO Investor Forum Kicks Off Amid Industry Optimism

Today, the BIO Investor Forum kicks off in San Francisco, Calif. BioWorld’s Catherine Shaffer paints …

BIO Investor Forum to Showcase NSF-funded Companies

No risk, no reward—that’s the concept driving the startups and entrepreneurs scheduled to present at …

12th Annual BIO Investor Forum Presenting Companies Announced

Looking to lose a few pounds? Don’t want to diet or exercise? You’re not alone: …

Prosensa's IPO and the Value of the BIO Investor Forum

Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of …

Call For Sessions - Speak Now. The Industry is Listening.

BIO is seeking to bring the most innovative thinkers in biotechnology together at the BIO …

Everyone is Engaging with China’s Biotech Industry, Including BIO

Countries all over the world are recognizing the importance of biotechnology to their economies, the …